Drug recall · May 27, 2026
Busulfan Injection recall
Why: Failed Impurities/Degradation Specifications
Class III: unlikely to cause harm, but breaks the rules (for example a labeling error).
The recall
- Product
Busulfan Injection, 60 mg per 10 mL (6 mg per mL), 8x10 mL Single-Dose Vials, Rx only, Mfd. for Sagent Pharmaceuticals, Schaumburg, IL 60195, Made in Canada, NDC 25021-241-10.
- Lots / codes
Lot #: 656412, Exp. Date 08/31/2026; 659646, Exp. Date 03/31/2027.
- Quantity
- Lot 656412: 6,200 vials. Lot 659646: 3,328 vials.
- Company
- Sagent Pharmaceuticals, Schaumburg, IL
- Distribution
- Nationwide within the United States
- Initiated
- May 4, 2026 · Voluntary: Firm initiated
- Classified
- May 18, 2026
- Reported
- May 27, 2026
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Busulfan
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.